In this issue:
Effectiveness and safety of NSAIDs and opioids for knee/hip OA
Association between prior RA and COVID-19 and its severity
CoronaVac inactivated vaccine in autoimmune rheumatic diseases
Rituximab for polymyalgia rheumatica
Antibody development after COVID-19 vaccines in autoimmune diseases
Radiographic progression of distal hand OA during DMARD therapy for RA
Systemic rheumatic disease patients vaccinated against COVID-19 have better outcomes
Long-term baricitinib treatment for RA
Birth outcomes for hydroxychloroquine-exposed pregnancies
Long-term efficacy and safety of guselkumab for PsA
Please login below to download this issue (PDF)